Abstract
Women's views on the menopause and hormone replacement therapy were explored using a questionnaire given to women attending one general practice who were having hormone replacement therapy under the supervision of their doctor. Sixty four women (67%) responded. Although only 5% of women had requested hormone replacement therapy from their general practitioner the majority of women indicated that they had been helped by hormone replacement therapy. Eight per cent of women were using hormone replacement therapy primarily to treat menopausal symptoms with only 6% of women using it primarily as prophylaxis against osteoporosis. Many women were correctly informed about the effects of hormone replacement therapy but mistaken beliefs about its side effects may indicate the need for further health education. The desire for further information was striking: 59% of women wanted further information about hormone replacement therapy, and 80% of women would have liked to have had more information about the menopause before its onset. The media appeared to be an important source of information about health matters: 61% of women obtained information about hormone replacement therapy from either the television, magazines or newspapers. The role of the media and health workers in health education is discussed.
Full text
PDF



Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Barlow D. H., Brockie J. A., Rees C. M. Study of general practice consultations and menopausal problems. Oxford General Practitioners Menopause Study Group. BMJ. 1991 Feb 2;302(6771):274–276. doi: 10.1136/bmj.302.6771.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Belchetz P. Hormone replacement treatment. BMJ. 1989 Jun 3;298(6686):1467–1468. doi: 10.1136/bmj.298.6686.1467. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Bergkvist L., Adami H. O., Persson I., Hoover R., Schairer C. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med. 1989 Aug 3;321(5):293–297. doi: 10.1056/NEJM198908033210505. [DOI] [PubMed] [Google Scholar]
- Bradley D. D., Wingerd J., Petitti D. B., Krauss R. M., Ramcharan S. Serum high-density-lipoprotein cholesterol in women using oral contraceptives, estrogens and progestins. N Engl J Med. 1978 Jul 6;299(1):17–20. doi: 10.1056/NEJM197807062990104. [DOI] [PubMed] [Google Scholar]
- Bungay G. T., Vessey M. P., McPherson C. K. Study of symptoms in middle life with special reference to the menopause. Br Med J. 1980 Jul 19;281(6234):181–183. doi: 10.1136/bmj.281.6234.181. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coope J. Menopause: diagnosis and treatment. Br Med J (Clin Res Ed) 1984 Oct 6;289(6449):888–890. doi: 10.1136/bmj.289.6449.888. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coope J., Roberts D. A clinic for the prevention of osteoporosis in general practice. Br J Gen Pract. 1990 Jul;40(336):295–299. [PMC free article] [PubMed] [Google Scholar]
- Coope J., Thomson J. M., Poller L. Effects of "natural oestrogen" replacement therapy on menopausal symptoms and blood clotting. Br Med J. 1975 Oct 18;4(5989):139–143. doi: 10.1136/bmj.4.5989.139. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Draper J., Roland M. Perimenopausal women's views on taking hormone replacement therapy to prevent osteoporosis. BMJ. 1990 Mar 24;300(6727):786–788. doi: 10.1136/bmj.300.6727.786. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Gath D., Iles S. Depression and the menopause. BMJ. 1990 May 19;300(6735):1287–1288. doi: 10.1136/bmj.300.6735.1287. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hunt K. Perceived value of treatment among a group of long-term users of hormone replacement therapy. J R Coll Gen Pract. 1988 Sep;38(314):398–401. [PMC free article] [PubMed] [Google Scholar]
- Hunt K., Vessey M. Long-term effects of postmenopausal hormone therapy. Br J Hosp Med. 1987 Nov;38(5):450-3, 456-60. [PubMed] [Google Scholar]
- Hunt K., Vessey M., McPherson K., Coleman M. Long-term surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol. 1987 Jul;94(7):620–635. doi: 10.1111/j.1471-0528.1987.tb03166.x. [DOI] [PubMed] [Google Scholar]
- Jensen J., Christiansen C., Rødbro P. Cigarette smoking, serum estrogens, and bone loss during hormone-replacement therapy early after menopause. N Engl J Med. 1985 Oct 17;313(16):973–975. doi: 10.1056/NEJM198510173131602. [DOI] [PubMed] [Google Scholar]
- Kadri A. Z. Hormone replacement therapy--a survey of perimenopausal women in a community setting. Br J Gen Pract. 1991 Mar;41(344):109–112. [PMC free article] [PubMed] [Google Scholar]
- Kaufman D. W., Miller D. R., Rosenberg L., Helmrich S. P., Stolley P., Schottenfeld D., Shapiro S. Noncontraceptive estrogen use and the risk of breast cancer. JAMA. 1984 Jul 6;252(1):63–67. [PubMed] [Google Scholar]
- Lindsay R., Hart D. M., Aitken J. M., MacDonald E. B., Anderson J. B., Clarke A. C. Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment. Lancet. 1976 May 15;1(7968):1038–1041. doi: 10.1016/s0140-6736(76)92217-0. [DOI] [PubMed] [Google Scholar]
- Montgomery J. C., Appleby L., Brincat M., Versi E., Tapp A., Fenwick P. B., Studd J. W. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet. 1987 Feb 7;1(8528):297–299. doi: 10.1016/s0140-6736(87)92026-5. [DOI] [PubMed] [Google Scholar]
- Munk-Jensen N., Pors Nielsen S., Obel E. B., Bonne Eriksen P. Reversal of postmenopausal vertebral bone loss by oestrogen and progestogen: a double blind placebo controlled study. Br Med J (Clin Res Ed) 1988 Apr 23;296(6630):1150–1152. doi: 10.1136/bmj.296.6630.1150. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Oei T. I., Zwart F. M. The assessment of life events: self-administered questionnaire versus interview. J Affect Disord. 1986 May-Jun;10(3):185–190. doi: 10.1016/0165-0327(86)90003-0. [DOI] [PubMed] [Google Scholar]
- Paganini-Hill A., Ross R. K., Henderson B. E. Postmenopausal oestrogen treatment and stroke: a prospective study. BMJ. 1988 Aug 20;297(6647):519–522. doi: 10.1136/bmj.297.6647.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Ross R. K., Paganini-Hill A., Mack T. M., Arthur M., Henderson B. E. Menopausal oestrogen therapy and protection from death from ischaemic heart disease. Lancet. 1981 Apr 18;1(8225):858–860. doi: 10.1016/s0140-6736(81)92138-3. [DOI] [PubMed] [Google Scholar]
- Shears M. R. Brighton practitioners' attitudes to HRT. Practitioner. 1989 Feb 8;233(1462):146–149. [PubMed] [Google Scholar]
- Studd J. W., Watson N. R., Montgomery J. Depression and the menopause. BMJ. 1990 Jun 23;300(6740):1653–1653. doi: 10.1136/bmj.300.6740.1653-a. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vessey M. P., Mann J. I. Female sex hormones and thrombosis. Epidemiological aspects. Br Med Bull. 1978 May;34(2):157–162. doi: 10.1093/oxfordjournals.bmb.a071486. [DOI] [PubMed] [Google Scholar]
- Weiss N. S., Ure C. L., Ballard J. H., Williams A. R., Daling J. R. Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. N Engl J Med. 1980 Nov 20;303(21):1195–1198. doi: 10.1056/NEJM198011203032102. [DOI] [PubMed] [Google Scholar]
- Ziel H. K., Finkle W. D. Increased risk of endometrial carcinoma among users of conjugated estrogens. N Engl J Med. 1975 Dec 4;293(23):1167–1170. doi: 10.1056/NEJM197512042932303. [DOI] [PubMed] [Google Scholar]